Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults

Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults

Abstract An unprecedented number of human infections with avian influenza A(H7N9) in the fifth epidemic wave during the winter of 2016–2017 in China and their antigenic divergence from the viruses that emerged in 2013 prompted development of updated vaccines for pandemic preparedness. We report on t...

Full description

Bibliographic Details
Main Authors: Christine M. Oshansky, James King, Di Lu, James Zhou, Corrina Pavetto, Gary Horwith, Karen Biscardi, Bai Nguyen, John J. Treanor, Li-Mei Chen, Brett Jepson, BPI17002 Study Coordination Team, Rick A. Bright, Robert A. Johnson, Vittoria Cioce, Ruben O. Donis
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-021-00287-7

Internet

https://doi.org/10.1038/s41541-021-00287-7

Similar Items